Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-04-15 @ 2:48 PM
Study NCT ID:
NCT01656720
Status:
COMPLETED
Last Update Posted:
2015-06-09
First Post:
2012-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
Sponsor:
Norgine
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NRL001-01/2011 (SEFI)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None